Aug 2026· NPP—Digital Psychiatry and Neuroscience· Vol 4· 0 citations· 44 references
Medicine
TL;DR
Five priorities define a translational agenda for 2026 and beyond: AI in mental health will succeed not through model performance alone, but through disciplined integration into clinical workflows, measurement systems, and governance structures that ensure safety, equity, and real-world effectiveness.
Abstract
Artificial intelligence (AI) has entered psychiatry at scale, yet its clinical impact remains constrained by a sizable gap between technical validation and real-world implementation. The central barriers are no longer computational, but infrastructural: unreliable measurement systems, incomplete governance frameworks, and insufficient standards for clinical evidence and integration. This paper synthesizes insights from a 2026 American College of Neuropsychopharmacology (ACNP) study group examining how to responsibly translate AI into clinical mental health care. Building on this perspective, we outline five priorities required for clinical impact. First, robust measurement and phenotyping infrastructure, such as reliable psychometrics, digital phenotyping, and standardized data pipelines, is essential for clinically meaningful AI. Second, the most immediate and scalable impact of AI lies in clinician-facing augmentation tools that reduce workflow burden, such as ambient documentation systems and structured decision-support pipelines, with important research to conduct here. Third, patient-facing AI interventions show promise but require rigorous safety evaluation, particularly for implicit suicide risk and heterogeneous treatment effects. Fourth, governance and equity frameworks must extend beyond privacy to address bias, digital literacy, and research integrity. Fifth, future progress requires moving beyond predictive models toward causal, mechanistic approaches to precision psychiatry that better inform treatment decisions and clinical action. Together, these priorities define a translational agenda for 2026 and beyond: AI in mental health will succeed not through model performance alone, but through disciplined integration into clinical workflows, measurement systems, and governance structures that ensure safety, equity, and real-world effectiveness. This paper synthesizes insights from a 2026 American College of Neuropsychopharmacology (ACNP) study group examining how to responsibly translate AI into clinical mental health care. Building on this perspective, we outline five priorities required for clinical impact. These priorities define a translational agenda for 2026 and beyond: AI in mental health will succeed not through model performance alone, but through disciplined integration into clinical workflows, measurement systems, and governance structures that ensure safety, equity, and real-world effectiveness.
It is argued that AI should be framed as an augmentation of - not a replacement for - the clinical relationship, with equity, consent and explainability treated as first-order design constraints.
Artificial intelligence (AI) is transforming mental health care by enabling novel approaches to assessment, outcome prediction, and treatment. However, the rapid growth of AI tools has outpaced evidence synthesis on their realworld clinical value, implementation barriers, and ethical risks, leaving clinicians and policymakers without clear guidance for responsible integration. This narrative review aimed to examine current AI applications in mental health care, identify their clinical benefits, implementation barriers, and ethical challenges, and define conditions for responsible integration that preserve the patient-clinician relationship. A structured literature search of PubMed, PsycINFO, and Scopus was conducted for peer reviewed English language articles published between January 2019 and March 2026. Studies addressing AI applications, benefits, implementation, or ethics in mental health were included and synthesised narratively into thematic categories. The review found that AI tools—for example, selfreferral chatbots that reduced waiting times and increased treatment uptake—provide expanded 24/7 access, improved clinical efficiency, and potential for individualised personalisation. Predictive models showed promise for treatment selection and risk stratification, while natural language processing unlocked unstructured clinical data. However, concerns included patient data privacy, algorithmic bias that may worsen existing inequities, potential erosion of the therapeutic relationship, and mixed acceptance among clinicians and patients. Many AI applications remain experimental, and regulatory frameworks have not kept pace with technological developments. This review did not include formal quality appraisal or quantitative synthesis; the evidence is limited by short followup periods, high dropout in chatbot trials, and a predominance of studies from highincome countries. Future research should employ longitudinal, codesigned, mixedmethods designs and pragmatic trials that evaluate clinical outcomes alongside equity, user trust, and the preservation of empathic, humanled care—rather than relying solely on uncontrolled implementation studies. AI should be responsibly integrated to augment, not replace, the clinical workforce. Successful application requires a balance between technological advancement, patient protection, and preservation of the patient-clinician relationship.
Shizal Nawaz, Laiba Nawaz, Hasnain Ali et al.· Digital Medicine· 0 citations
The clinical impact of psychiatric AI will likely depend less on algorithmic novelty alone than on clearer clinical targets, prospective validation, implementation trials, patient‐centered evaluation, equity‐sensitive generalizability, and mental health–specific governance.
Esteban Zavaleta-Monestel, L. Herrera-Jiménez, Sofía Suárez-Sánchez et al.· Psychiatric Research and Cli...· 0 citations
Cognitive and mental health (CMH) disorders are increasingly prevalent worldwide and pose significant societal, clinical, and economic challenges. While conventional mental health support methods remain limited by scalability and reactivity, recent advances in artificial intelligence have opened new opportunities for scalable, proactive, and personalized mental health support. Rapid progress has been made in areas such as mental health assessment, empathetic conversational agents, and AI-assisted psychological interventions; however, these efforts remain fragmented across disciplines, and critical challenges related to reliability, interpretability, ethics, and real-world deployment persist. To address these gaps, we propose the International Workshop on AI for Cognitive and Mental Health Support (AI4Mental), a half-day interdisciplinary forum that brings together researchers and practitioners from data mining, machine learning, NLP, HCI, healthcare, and social sciences. The workshop focuses on three complementary pillars: AI as Assessment, AI as Emotional Support, and AI as Psychological Intervention, covering topics ranging from multimodal mental health detection and longitudinal risk modeling to empathetic dialogue systems and responsible interventions. By consolidating emerging research and fostering cross-disciplinary dialogue, AI4Mental aims to advance trustworthy, effective, and socially responsible AI solutions for cognitive and mental health support, aligning closely with SIGKDD's mission on data science for social good.
Xiangmeng Wang, Hao-Yang Li, Chen Li et al.· Proceedings of the 32nd ACM...· 0 citations
ABSTRACT Ambient artificial intelligence (AI) scribes are systems that automatically generate clinical documentation from clinician‐patient conversations and are being deployed at accelerating pace across US health systems. Early evaluations report reduced documentation burden, improved clinician well‐being, and perceived efficiency gains, reinforcing a narrative of inevitability. Yet this frontline framing understates a more consequential issue: ambient scribes outsource the “first mile” of clinical documentation, thereby reshaping the production of clinical data and the learning health systems (LHSs) that depend on documentation as foundational infrastructure. This paper argues that ambient AI scribes should be understood not merely as workflow tools, but as emerging infrastructure that will materially shape the capacity and capabilities of LHSs. Drawing on infrastructure studies and LHS frameworks, we conceptualize clinical documentation as the epistemic substrate through which encounters are translated into analyzable data that power quality measurement, predictive modeling, clinical decision support, and institutional learning. When this translation is algorithmically mediated by proprietary systems, design choices, training data, and integration pathways can introduce systematic documentation errors that propagate downstream, often invisibly, through analytic pipelines. Synthesizing emerging evidence, we highlight risks including hallucinated clinical details, omission of safety‐critical information, and differential performance across patient populations with diverse accents or speech patterns. These risks mirror classic infrastructural properties described by Star: embeddedness, dependence on the installed base, wide propagation, and visibility primarily upon breakdown. From this perspective, ambient scribes may quietly reshape documentation norms, data quality, and learning trajectories well before downstream effects are routinely assessed. We conclude by outlining a governance agenda grounded in LHS principles: documentation‐quality metrics, drift monitoring, equity‐focused evaluation, transparency, and multi‐stakeholder stewardship. Without such oversight, ambient AI scribes risk stabilizing an infrastructural layer that delivers short‐term relief while eroding the long‐term integrity, equity, and trustworthiness of learning health systems.
T. Togunwa, Jodyn E. Platt· Learning Health Systems· 0 citations
Artificial intelligence (AI) is increasingly embedded in health systems globally and has the potential to improve efficiency, diagnostic accuracy, and decision support. However, its benefits remain unevenly distributed, particularly in low- and middle-income countries (LMICs). Models developed using datasets from specific populations may perform poorly in other settings, reinforcing structural inequities rather than correcting them. This viewpoint proposes a composite framework, the AI in Healthcare Equity Index (AIHEI), to support measurable assessment of equity in health AI systems. The AIHEI is designed to assess equity across five domains: data representation, algorithmic fairness, transparency and explainability, governance and oversight, and community impact and benefit sharing. By generating a standardised score, the index could enable comparisons across technologies, incentivise improvement, and support regulation, procurement, publication, and funding decisions. Pilots across diverse health domains and geographic settings are needed to assess feasibility, refine domain weighting, and evaluate reliability, reproducibility, and validity. Important challenges include contextual definitions of fairness, data sovereignty, post-deployment monitoring, and the risk of metric gaming. Quantifying equity in health AI is essential to ensure that AI does not create, widen, or exacerbate existing disparities by neglecting underserved populations. A common, objective measure of AI-related health equity can help move the field from ethical aspiration toward measurable accountability, monitoring, and enforcement.
Basile Njei, U. S. Kanmounye, L. Bain et al.· International Journal for Eq...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
